Global Antidiabetic Drug Market Research Report 2023(Status and Outlook)

Global Antidiabetic Drug Market Research Report 2023(Status and Outlook)



Report Overview

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug

The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.

The Global Antidiabetic Drug Market Size was estimated at USD 44610.00 million in 2022 and is projected to reach USD 86932.27 million by 2029, exhibiting a CAGR of 10.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Antidiabetic Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antidiabetic Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antidiabetic Drug market in any manner.

Global Antidiabetic Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi-Aventis

Eli Lilly

Oramed

Takeda

Boehringer Ingelheim

Novo Nordisk

Halozyme Therapeutics

Bristol-Myers Squibb

Pfizer

Tonghua Dongbao

Biocon

Wockhardt

Market Segmentation (by Type)

Alpha-Glucosidase Inhibitors

Biguanides, Sulphonylureas

Glp-1 Agonist

Meglitinides

Dpp-4 Inhibitors

Sglt–2

Thiazolodinediones

Market Segmentation (by Application)

Hospitals & Clinics

Home-care

Ambulatory Surgical Centers (ASCs)

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antidiabetic Drug Market

Overview of the regional outlook of the Antidiabetic Drug Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antidiabetic Drug
1.2 Key Market Segments
1.2.1 Antidiabetic Drug Segment by Type
1.2.2 Antidiabetic Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antidiabetic Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Antidiabetic Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Antidiabetic Drug Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antidiabetic Drug Market Competitive Landscape
3.1 Global Antidiabetic Drug Sales by Manufacturers (2018-2023)
3.2 Global Antidiabetic Drug Revenue Market Share by Manufacturers (2018-2023)
3.3 Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antidiabetic Drug Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Antidiabetic Drug Sales Sites, Area Served, Product Type
3.6 Antidiabetic Drug Market Competitive Situation and Trends
3.6.1 Antidiabetic Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antidiabetic Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antidiabetic Drug Industry Chain Analysis
4.1 Antidiabetic Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antidiabetic Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antidiabetic Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antidiabetic Drug Sales Market Share by Type (2018-2023)
6.3 Global Antidiabetic Drug Market Size Market Share by Type (2018-2023)
6.4 Global Antidiabetic Drug Price by Type (2018-2023)
7 Antidiabetic Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antidiabetic Drug Market Sales by Application (2018-2023)
7.3 Global Antidiabetic Drug Market Size (M USD) by Application (2018-2023)
7.4 Global Antidiabetic Drug Sales Growth Rate by Application (2018-2023)
8 Antidiabetic Drug Market Segmentation by Region
8.1 Global Antidiabetic Drug Sales by Region
8.1.1 Global Antidiabetic Drug Sales by Region
8.1.2 Global Antidiabetic Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antidiabetic Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antidiabetic Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antidiabetic Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antidiabetic Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antidiabetic Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi-Aventis
9.1.1 Sanofi-Aventis Antidiabetic Drug Basic Information
9.1.2 Sanofi-Aventis Antidiabetic Drug Product Overview
9.1.3 Sanofi-Aventis Antidiabetic Drug Product Market Performance
9.1.4 Sanofi-Aventis Business Overview
9.1.5 Sanofi-Aventis Antidiabetic Drug SWOT Analysis
9.1.6 Sanofi-Aventis Recent Developments
9.2 Eli Lilly
9.2.1 Eli Lilly Antidiabetic Drug Basic Information
9.2.2 Eli Lilly Antidiabetic Drug Product Overview
9.2.3 Eli Lilly Antidiabetic Drug Product Market Performance
9.2.4 Eli Lilly Business Overview
9.2.5 Eli Lilly Antidiabetic Drug SWOT Analysis
9.2.6 Eli Lilly Recent Developments
9.3 Oramed
9.3.1 Oramed Antidiabetic Drug Basic Information
9.3.2 Oramed Antidiabetic Drug Product Overview
9.3.3 Oramed Antidiabetic Drug Product Market Performance
9.3.4 Oramed Business Overview
9.3.5 Oramed Antidiabetic Drug SWOT Analysis
9.3.6 Oramed Recent Developments
9.4 Takeda
9.4.1 Takeda Antidiabetic Drug Basic Information
9.4.2 Takeda Antidiabetic Drug Product Overview
9.4.3 Takeda Antidiabetic Drug Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Antidiabetic Drug SWOT Analysis
9.4.6 Takeda Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Antidiabetic Drug Basic Information
9.5.2 Boehringer Ingelheim Antidiabetic Drug Product Overview
9.5.3 Boehringer Ingelheim Antidiabetic Drug Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Antidiabetic Drug SWOT Analysis
9.5.6 Boehringer Ingelheim Recent Developments
9.6 Novo Nordisk
9.6.1 Novo Nordisk Antidiabetic Drug Basic Information
9.6.2 Novo Nordisk Antidiabetic Drug Product Overview
9.6.3 Novo Nordisk Antidiabetic Drug Product Market Performance
9.6.4 Novo Nordisk Business Overview
9.6.5 Novo Nordisk Recent Developments
9.7 Halozyme Therapeutics
9.7.1 Halozyme Therapeutics Antidiabetic Drug Basic Information
9.7.2 Halozyme Therapeutics Antidiabetic Drug Product Overview
9.7.3 Halozyme Therapeutics Antidiabetic Drug Product Market Performance
9.7.4 Halozyme Therapeutics Business Overview
9.7.5 Halozyme Therapeutics Recent Developments
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Antidiabetic Drug Basic Information
9.8.2 Bristol-Myers Squibb Antidiabetic Drug Product Overview
9.8.3 Bristol-Myers Squibb Antidiabetic Drug Product Market Performance
9.8.4 Bristol-Myers Squibb Business Overview
9.8.5 Bristol-Myers Squibb Recent Developments
9.9 Pfizer
9.9.1 Pfizer Antidiabetic Drug Basic Information
9.9.2 Pfizer Antidiabetic Drug Product Overview
9.9.3 Pfizer Antidiabetic Drug Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
9.10 Tonghua Dongbao
9.10.1 Tonghua Dongbao Antidiabetic Drug Basic Information
9.10.2 Tonghua Dongbao Antidiabetic Drug Product Overview
9.10.3 Tonghua Dongbao Antidiabetic Drug Product Market Performance
9.10.4 Tonghua Dongbao Business Overview
9.10.5 Tonghua Dongbao Recent Developments
9.11 Biocon
9.11.1 Biocon Antidiabetic Drug Basic Information
9.11.2 Biocon Antidiabetic Drug Product Overview
9.11.3 Biocon Antidiabetic Drug Product Market Performance
9.11.4 Biocon Business Overview
9.11.5 Biocon Recent Developments
9.12 Wockhardt
9.12.1 Wockhardt Antidiabetic Drug Basic Information
9.12.2 Wockhardt Antidiabetic Drug Product Overview
9.12.3 Wockhardt Antidiabetic Drug Product Market Performance
9.12.4 Wockhardt Business Overview
9.12.5 Wockhardt Recent Developments
10 Antidiabetic Drug Market Forecast by Region
10.1 Global Antidiabetic Drug Market Size Forecast
10.2 Global Antidiabetic Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antidiabetic Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antidiabetic Drug Market Size Forecast by Region
10.2.4 South America Antidiabetic Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antidiabetic Drug by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Antidiabetic Drug Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Antidiabetic Drug by Type (2024-2029)
11.1.2 Global Antidiabetic Drug Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Antidiabetic Drug by Type (2024-2029)
11.2 Global Antidiabetic Drug Market Forecast by Application (2024-2029)
11.2.1 Global Antidiabetic Drug Sales (K MT) Forecast by Application
11.2.2 Global Antidiabetic Drug Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings